EUCTR2012-000515-80-ES进行中（未招募）不适用
Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study.
Juan Córdoba0 个研究点开始时间: 2012年6月26日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients> 18 and <70 years of age.
- •- Excessive alcohol consumption prior to admission.
- •- Jaundice in the last 3 months.
- •- Modified Maddrey index> 32.
- •- Confirmation of acute alcoholic hepatitis histology defined in the protocol
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 46
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •- Advanced or terminal chronic illness
- •- Hepatocarcinoma
- •- Complete portal thrombosis.
- •- Autoimmune liver disease.
- •- Infection with hepatitis B and C, or HIV.
- •- Use of rifaximin in the last 2 months.
研究者
相似试验
进行中（未招募）
2 期
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 TrialJPRN-jRCT2031190137Ohkubo Hidenori12
招募中
2 期
Prospective study on suppression of cholangitis using rifaximin after SEMS placement for distal malignant biliary obstructioJPRN-jRCTs051210173Ikezawa Kenji30
招募中
不适用
Efficacy and safety of Rifaximin for the treatment of liver cirrhosis with covert hepatic encephalopathyiver cirrhosisJPRN-UMIN000044657Wakayama Medical University40
招募中
3 期
The effect of rifaximin in IBSIrritable bowel syndrome.Irritable bowel syndromeIRCT20221211056775N1Arak University of Medical Sciences60
进行中（未招募）
1 期
Effect of administration of Rifaximin on the increased portal pressure of patients with liver cirrhosis and esophageal varices already treated with propranololEUCTR2014-000102-35-ITClinica Medica 560